These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 16611274

  • 1. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1137-41. PubMed ID: 16611274
    [Abstract] [Full Text] [Related]

  • 2. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.
    Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Syriopoulou VP, Goutas N, Vlachodimitropoulos D, Anagnou NP, Roma-Giannikou E.
    J Clin Pharm Ther; 2010 Feb 15; 35(1):93-7. PubMed ID: 20175817
    [Abstract] [Full Text] [Related]

  • 3. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z, Derijks LJ, Stokkers PC, Vogels EW, van Kampen AH, Curvers WL, Cohn D, van Deventer SJ, Hommes DW.
    Clin Gastroenterol Hepatol; 2006 Jan 15; 4(1):44-9. PubMed ID: 16431304
    [Abstract] [Full Text] [Related]

  • 4. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q, Zhu Q, Shang Y, Gao M, Si J.
    Digestion; 2009 Jan 15; 79(1):58-63. PubMed ID: 19252404
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z, Xiang G, Minhu C, Liang D, Feng X, Min H, Pinjin H.
    Ther Drug Monit; 2012 Dec 15; 34(6):695-701. PubMed ID: 23149442
    [Abstract] [Full Text] [Related]

  • 7. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
    Ansari A, Arenas M, Greenfield SM, Morris D, Lindsay J, Gilshenan K, Smith M, Lewis C, Marinaki A, Duley J, Sanderson J.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):973-83. PubMed ID: 18616518
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease.
    Winter J, Walker A, Shapiro D, Gaffney D, Spooner RJ, Mills PR.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):593-9. PubMed ID: 15352906
    [Abstract] [Full Text] [Related]

  • 9. Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease.
    Van Dieren JM, Hansen BE, Kuipers EJ, Nieuwenhuis EE, Van der Woude CJ.
    Aliment Pharmacol Ther; 2007 Sep 01; 26(5):643-52. PubMed ID: 17697198
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
    Gisbert JP, Niño P, Rodrigo L, Cara C, Guijarro LG.
    Am J Gastroenterol; 2006 Dec 01; 101(12):2769-76. PubMed ID: 17026564
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
    Odahara S, Uchiyama K, Kubota T, Ito Z, Takami S, Kobayashi H, Saito K, Koido S, Ohkusa T.
    PLoS One; 2015 Dec 01; 10(9):e0137798. PubMed ID: 26360046
    [Abstract] [Full Text] [Related]

  • 15. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine.
    Buster EH, van Vuuren HJ, Zondervan PE, Metselaar HJ, Tilanus HW, de Man RA.
    Eur J Gastroenterol Hepatol; 2008 Jan 01; 20(1):68-72. PubMed ID: 18090994
    [Abstract] [Full Text] [Related]

  • 16. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.
    Zabala-Fernández W, Barreiro-de Acosta M, Echarri A, Carpio D, Lorenzo A, Castro J, Martínez-Ares D, Pereira S, Martin-Granizo I, Corton M, Carracedo A, Barros F.
    J Gastrointestin Liver Dis; 2011 Sep 01; 20(3):247-53. PubMed ID: 21961091
    [Abstract] [Full Text] [Related]

  • 17. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
    Breen DP, Marinaki AM, Arenas M, Hayes PC.
    Liver Transpl; 2005 Jul 01; 11(7):826-833. PubMed ID: 15973722
    [Abstract] [Full Text] [Related]

  • 18. Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy.
    Palmieri O, Latiano A, Bossa F, Vecchi M, D'Incà R, Guagnozzi D, Tonelli F, Cucchiara S, Valvano MR, Latiano T, Andriulli A, Annese V.
    Aliment Pharmacol Ther; 2007 Sep 01; 26(5):737-45. PubMed ID: 17697207
    [Abstract] [Full Text] [Related]

  • 19. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
    Zhu Q, Cao Q.
    Chin Med J (Engl); 2012 Oct 01; 125(20):3665-70. PubMed ID: 23075721
    [Abstract] [Full Text] [Related]

  • 20. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
    Aghdaie MH, Azarpira N, Geramizadeh B, Sagheb M, Darai M, Rahsaz M, Malekhoseini SA.
    Exp Clin Transplant; 2011 Aug 01; 9(4):241-6. PubMed ID: 21819368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.